Clinical Trials Logo
  1. Home
  2. End Stage Liver Disease
  3. NCT02166177

Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients — ThRIL  

End-stage Liver Disease Clinical Trial

Official title:
Pilot Study Evaluating the Safety and Efficacy Profile of Regulatory T Cell Therapy in Liver Transplant Recipients

Clinical Trial Summary

'ThRIL' aims to explore the feasibility, safety and efficacy of TR002, a regulatory cell therapy, as adjunct immunosuppressive treatment in the context of liver transplantation

Clinical Trial Description

Stage I: To evaluate the safety of administering TR002 to liver transplant recipients.

Stage II: To evaluate the efficacy of TR002 administration in allowing for the discontinuation of immunosuppressive therapy in liver transplant recipients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02166177
Study type Interventional
Source Guy's and St Thomas' NHS Foundation Trust
Contact
Status Completed
Phase Phase 1/Phase 2
Start date June 2014
Completion date January 22, 2018
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05001009 - Goals of Care Conversations Study N/A
Completed NCT01707810 - Prospective Trial Comparing Conventional Versus Piggyback Method in Venous Drainage of the Transplanted Liver N/A
Terminated NCT00656266 - Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation Phase 4
Enrolling by invitation NCT02478151 - Using Ex-vivo Normothermic Machine Perfusion With the Organox Metra™ Device to Store Human Livers for Transplantation Phase 1
Completed NCT00913276 - Conditioning With Volatile Anesthetics in Liver Transplantation N/A
Completed NCT04572373 - Supplements SMOF in TPN for Liver Transplantation Recipients
Not yet recruiting NCT06242405 - Effect of Different Frequencies of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD N/A
Not yet recruiting NCT06400498 - Surprise Question in End of Life (SeQuEL) Care and the Effect of Prompting Palliative Care Consultation: End-Stage Liver Disease N/A
Not yet recruiting NCT05750329 - Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC) N/A